Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Comparison of Combined ACB and IPACK Versus ACB Alone for Postoperative Pain Management After ACL Reconstruction

18. november 2026 oppdatert av: Kazi Mahzabin Arin, Bangladesh Medical University

Evaluation of Combined Adductor Canal Block and Infiltration Between the Popliteal Artery and Capsule of the Knee (IPACK) Block Versus Adductor Canal Block (ACB) Alone on Postoperative Analgesia Following Anterior Cruciate Ligament (ACL) Reconstruction-A Randomized Controlled Trial

This randomized controlled trial aims to evaluate whether combining an adductor canal block (ACB) with an infiltration between the popliteal artery and the knee capsule (IPACK) provides better postoperative analgesia than ACB alone in patients undergoing anterior cruciate ligament reconstruction.

A total of 72 adult patients aged 18-50 years with American Society of Anesthesiologists (ASA) physical status I-II will be randomly allocated into two groups. The intervention group will receive ultrasound-guided combined ACB and IPACK blocks, while the comparator group will receive ultrasound-guided ACB alone. Both groups will receive spinal anesthesia and standardized postoperative analgesia.

Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS) at 2, 6, 12, and 24 hours after surgery. Other outcomes will include total opioid consumption during the first 24 hours, postoperative quality of recovery assessed by the QoR-15 questionnaire, time to first rescue analgesic request, maximum walking distance, and block-related complications.

The findings are expected to provide evidence on the effectiveness of adding an IPACK block to ACB to improve postoperative pain management following ACL reconstruction.

Studieoversikt

Detaljert beskrivelse

Anterior cruciate ligament reconstruction (ACLR) is a commonly performed orthopedic procedure for patients with anterior cruciate ligament injuries. Despite its minimally invasive arthroscopic approach, the procedure is frequently associated with significant postoperative pain due to surgical tissue injury, graft harvesting, tourniquet application, and postoperative inflammatory responses. Inadequate pain management may interfere with early mobilization, delay rehabilitation, increase opioid consumption, and negatively affect postoperative recovery.

Effective postoperative analgesia is therefore an important component of perioperative care following anterior cruciate ligament (ACL) reconstruction. Multimodal analgesia, including regional anesthesia techniques, is increasingly used to improve pain control while minimizing opioid-related adverse effects.

The adductor canal block (ACB) is an ultrasound-guided regional anesthesia technique that primarily targets the saphenous nerve and provides analgesia to the anterior and medial aspects of the knee while generally preserving quadriceps muscle strength. However, adductor canal block (ACB) alone may provide inadequate analgesia for pain originating from the posterior aspect of the knee.

The infiltration between the popliteal artery and the knee capsule (IPACK) block is an ultrasound-guided regional anesthesia technique designed to provide analgesia to the posterior knee capsule while minimizing motor blockade. Combining infiltration between the popliteal artery and the knee capsule (IPACK) with adductor canal block (ACB) may provide more comprehensive postoperative analgesia by addressing both anterior-medial and posterior knee pain.

The present randomized controlled trial is designed to evaluate the effectiveness of combined ultrasound-guided adductor canal block (ACB) and infiltration between the popliteal artery and the knee capsule (IPACK) blocks compared with ultrasound-guided adductor canal block (ACB) alone in patients undergoing arthroscopic anterior cruciate ligament reconstruction.

The study will include 72 adult patients aged 18-50 years with American Society of Anesthesiologists (ASA) physical status I-II who are scheduled for anterior cruciate ligament (ACL) reconstruction. Participants will be recruited using consecutive sampling and randomly allocated 1:1 to two study groups using computer-generated block randomization. Allocation concealment will be maintained using sequentially numbered, opaque, sealed envelopes. The outcome assessor will remain blinded to the group allocation.

Participants allocated to this group will receive an ultrasound-guided adductor canal block with 20 mL of 0.25% bupivacaine, combined with an ultrasound-guided IPACK block with an additional 20 mL of 0.25% bupivacaine.

Participants allocated to this group will receive ultrasound-guided adductor canal block alone using 20 mL of 0.25% bupivacaine.

Both groups will undergo surgery under standard spinal anesthesia. Standardized postoperative analgesia will be provided using intravenous paracetamol (15 mg/kg) every 8 hours. Rescue analgesia with intravenous morphine (3 mg) will be administered when the postoperative Numeric Rating Scale (NRS) pain score exceeds 5, with repeat administration if required.

The study findings will help determine whether adding an IPACK block to an adductor canal block provides improved postoperative analgesia compared with ACB alone following ACL reconstruction.

Studietype

Intervensjonell

Registrering (Antatt)

72

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

      • Dhaka, Bangladesh, 1000
        • Bangladesh Medical University
        • Ta kontakt med:
        • Hovedetterforsker:
          • Mosharof Hossain, MD

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 50 år (Voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Patient with anterior cruciate ligament injury requiring surgery.
  • Adult patients
  • Patients aged between 18 and 50 years
  • BMI
  • Patients of either sex.
  • American Society of Anesthesiologists (ASA) physical status I-II.

Exclusion Criteria:

  • Known allergy to local anesthetic drugs
  • Coagulopathy or patients receiving anticoagulant therapy
  • Infection at the site of injection
  • Chronic opioid use or opioid dependence
  • Pregnancy

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Group IPACK+ACB

Participants in this group will receive an ultrasound-guided adductor canal block (ACB) with 20 mL of 0.25% bupivacaine, combined with an ultrasound-guided infiltration between the popliteal artery and the knee capsule (IPACK) using an additional 20 mL of 0.25% bupivacaine. Both blocks will be administered before surgery. Standard spinal anesthesia and postoperative analgesia will be provided according to the study protocol.

Participants will receive an ultrasound-guided combined adductor canal block (ACB) and an infiltration between the popliteal artery and the knee capsule (IPACK) before surgery. The ACB will be performed using 20 mL of 0.25% bupivacaine administered around the saphenous nerve in the adductor canal. The IPACK block will be performed using an additional 20 mL of 0.25% bupivacaine injected into the interspace between the popliteal artery and the posterior capsule of the knee under ultrasound guidance. Both blocks will be administered as a combined regional anesthesia technique for postoperative pain management following anterior cruciate ligament reconstruction.

Aktiv komparator: Group ACB

Participants in this group will receive an ultrasound-guided adductor canal block (ACB) alone using 20 mL of 0.25% bupivacaine before surgery. No IPACK block will be administered. Standard spinal anesthesia and postoperative analgesia will be provided according to the study protocol.

Ultrasound-guided adductor canal block will be performed with the participant in the supine position. A linear ultrasound transducer will be placed over the mid-thigh to identify the femoral artery and adjacent saphenous nerve beneath the sartorius muscle. After confirming needle placement and careful aspiration, 20 mL of 0.25% bupivacaine will be injected around the saphenous nerve in 5 mL increments.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Postoperative Pain Intensity Measured by Numeric Rating Scale (NRS)
Tidsramme: 2, 6, 12, and 24 hours after surgery

Postoperative pain intensity will be assessed using the 11-point Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain), both at rest and during movement (knee flexion greater than 45 degrees). Pain scores will be recorded and compared between the two study groups.

2, 6, 12, and 24 hours after surgery

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Time to First Analgesic Request
Tidsramme: First 24 hours after surgery

The time from the end of surgery to the first request for postoperative rescue analgesia will be recorded in hours and compared between the two study groups.

First 24 hours after surgery
Postoperative Quality of Recovery Measured by QoR-15 Score
Tidsramme: 24 hours after surgery

Postoperative quality of recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15). The total score ranges from 0 to 150, with higher scores indicating better recovery quality. Scores will be compared between the two study groups.

24 hours after surgery
Adverse Effects
Tidsramme: Up to 24 hours following surgery

Incidence of Block-Related Adverse Effects

Up to 24 hours following surgery
Total Opioid Consumption During the First 24 Hours After Surgery
Tidsramme: First 24 hours after surgery

Measure and compare the total opioid consumption between the two study groups during the first 24 hours after surgery. Opioid consumption will be recorded and expressed in morphine-equivalent doses (mg).

First 24 hours after surgery

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. desember 2026

Primær fullføring (Antatt)

31. mai 2027

Studiet fullført (Antatt)

31. mai 2027

Datoer for studieregistrering

Først innsendt

12. november 2026

Først innsendt som oppfylte QC-kriteriene

18. november 2026

Først lagt ut (Faktiske)

20. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

20. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

18. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Studiedata/dokumenter

  1. Studieprotokoll
    Informasjonsidentifikator: pain.medicine@bmu.ac.bd

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere